ATC code - C09B
SpainAce inhibitors, combinations
Drugs with code C09B
-
Form: capsules, hard
Active substance Dosage ramipril 10,0 mg amlodipine besylate 13,868 mg ATC code: C09B, C09BB, C09BB07
Manufacturer: Sanofi Aventis S.A.
-
Form: capsules, hard
Active substance Dosage ramipril 5,0 mg amlodipine besylate 13,868 mg ATC code: C09B, C09BB, C09BB07
Manufacturer: Sanofi Aventis S.A.
-
Form: capsules, hard
Active substance Dosage ramipril 10,0 mg amlodipine besylate 6,934 mg ATC code: C09B, C09BB, C09BB07
Manufacturer: Sanofi Aventis S.A.
-
Form: capsules, hard
Active substance Dosage ramipril 5,0 mg amlodipine besylate 6,934 mg ATC code: C09B, C09BB, C09BB07
Manufacturer: Sanofi Aventis S.A.
-
Form: tablets
Active substance Dosage perindopril arginine 3,5 mg amlodipine besylate 3,4675 mg ATC code: C09B, C09BB, C09BB04
Manufacturer: Les Laboratoires Servier
-
Form: tablets
Active substance Dosage perindopril arginine 7 mg amlodipine besylate 6,935 mg ATC code: C09B, C09BB, C09BB04
Manufacturer: Les Laboratoires Servier
-
Form: tablets, film-coated
Active substance Dosage perindopril arginine 7 mg amlodipine 5 mg indapamide 2,5 mg ATC code: C09B, C09BX, C09BX01
Manufacturer: Les Laboratoires Servier
-
Form: tablets
Active substance Dosage delapril hydrochloride 30,0 mg manidipine hydrochloride 10,0 mg ATC code: C09B, C09BB, C09BB12
Manufacturer: Chiesi Espana S.A.U.
-
Form: tablets, film-coated
Active substance Dosage lercanidipine hydrochloride 10 mg enalapril maleate 10 mg ATC code: C09B, C09BB, C09BB02
Manufacturer: Casen Recordati S.L.
-
Form: tablets, film-coated
Active substance Dosage lercanidipine hydrochloride 10 mg enalapril maleate 20 mg ATC code: C09B, C09BB, C09BB02
Manufacturer: Casen Recordati S.L.
-
Form: tablets, film-coated
Active substance Dosage enalapril maleate 20,00 mg lercanidipine hydrochloride 20,00 mg ATC code: C09B, C09BB, C09BB02
Manufacturer: Casen Recordati S.L.
-
Form: tablets
Active substance Dosage lisinopril 20 mg hydrochlorothiazide 12,5 mg ATC code: C09B, C09BA, C09BA03
Manufacturer: Atnahs Pharma Netherlands Bv.